IndraLab

Statements

Glucocorticoid inhibits MAP3K7. 1 / 1

| 1

reach

"We demonstrate that GC, a mainstay therapy for IBD, fails to suppress the activation of TAK1 and downstream signaling mediators that induce intestinal inflammation."

28373409

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Glucocorticoid inhibits MAP3K7. 1 / 1

INDRA sources:

Databases

Reading